Primary study · included by 1 review

Initial Multicenter Experience with [161Tb]Tb-PSMA in [177Lu]Lu-PSMA-Refractory Metastatic Castration-Resistant Prostate Cancer: Preliminary Results.

Kucuk 2025 · Kucuk Nuriye Ozlem, Coskun Nazim, Araz Mine, et al. · Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2025

Included by

Beyond [177Lu]Lu-PSMA: a meta-analysis of safety and efficacy of emerging PSMA radioligand therapy agents.

Non-Cochrane · intervention · 2026 · cited as Kucuk 2025 · Reference list refs 21-53; Table 2; Supplementary Table 5

The review does not say which of its outcomes this study informs.

1 including review in total.